Healthium Medtech, a global medical technology company with an expanding portfolio spanning surgical, post-surgical, advanced wound care, arthroscopy, and infection prevention, has entered into an exclusive partnership with Tisgenx, Inc.—a U.S.-based
Maverick Simulation Solutions, a frontrunner in the field of advanced medical simulation technology, has achieved a significant milestone by installing India’s first Anatomage Table at Vardhman Mahavir Medical College (VMMC) and Safdarjung Hospital
The Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with the Serum Institute of India (SII) Pvt. Ltd. the world’s largest vaccine manufacturer and part of the Cyrus Poonawalla Group to strengthen global pandemic preparedness
Aurobindo Pharma's promoter group has successfully secured around 2,000 crore with a dual-tranche financing structure intended for platform acquisitions, which includes the Taj Banjara asset situated in Hyderabad. The funds are being directed
Cadila Pharmaceuticals, one of the leading research-based pharmaceutical companies in India, has now launched Dlorfast-M Tablets. It is a new fixed-dose combination tablet that contains 5 mg of Desloratadine (a novel antihistamine) and 10 mg...
Orbital Therapeutics, a privately held biotech company, was purchased by Bristol Myers Squibb (BMS) for $1.5 billion in cash. The agreement, which was made public on October 10, 2025, gives BMS access to Orbital's exclusive RNA-based platform and
From December 19 to 21, 2025, the 21st PharmaTech Expo & LabTech Expo will be held at the Bengaluru International Exhibition Centre (BIEC), Bengaluru, in conjunction with the Contract Manufacturing and Raw & Packaging Material Expo. Professionals
The US health agency has said that Zydus Lifesciences and Dr. Reddy's Laboratories, two major drug companies, are recalling their goods in the US due to production problems
A Guideline Development Group (GDG) is being assembled by the World Health Organization (WHO) to create evidence-based guidelines for human T-cell lymphotropic virus-1 (HTLV-1)
Turbine, a prominent company focused on the virtualization of biological experiments using AI, has announced a partnership with AstraZeneca to evaluate the capability of Turbine’s platform in rationalizing the discovery of antibody-drug conjugates
.jpg)
, CDSCO.jpg)